131I gastric uptake with and without omeprazole in patients undergoing radioiodine therapy for differentiated thyroid carcinoma

被引:2
作者
Castro, Gabriel [1 ]
Berrocal, Isabel [1 ]
Carmona, Jaime [1 ]
Gonzalez, Javiera [1 ]
Gonzalez, Patricio [1 ]
机构
[1] Univ Chile, Clin Hosp, Nucl Med Sect, Independencia, Santiago De Chi, Chile
关键词
Omeprazole; Differentiate Thyroid Cancer; Differentiate Thyroid Carcinoma; Radioiodine Therapy; Visual Score;
D O I
10.1007/s00259-012-2104-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1356 / 1357
页数:2
相关论文
共 50 条
[31]   Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131I Ablation Therapy for Differentiated Thyroid Cancer [J].
Hasbek, Zekiye ;
Turgut, Bulent ;
Kilicli, Fatih ;
Altuntas, Emine Elif ;
Yucel, Birsen .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (06) :2523-2527
[32]   Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy [J].
Lin, Baiqiang ;
Zhao, Fuya ;
Liu, Yang ;
Sun, Jiayu ;
Feng, Jing ;
Zhao, Lei ;
Wang, Haoran ;
Chen, Hongye ;
Yan, Wei ;
Guo, Xiao ;
Shi, Shang ;
Li, Zhiyong ;
Wang, Shuang ;
Lu, Yu ;
Zheng, Jianjun ;
Wei, Yunwei .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[33]   Influence of Radioiodine Therapy on Oral Health and Salivary Production in Patients With Differentiated Thyroid Carcinoma [J].
Terrazas, Jorge Ramires ;
Marins, Clarissa Robalinho Penna ;
Correa, Maria Elvira Pizzigatti ;
da Assumpca, Ligia Vera Montali ;
Zantut-Wittmann, Denise Engelbrecht .
ENDOCRINE PRACTICE, 2025, 31 (04) :439-446
[34]   Influence of Glucocorticoid Therapy on intratherapeutic Biodistribution of 131I Radioiodine Therapy in Graves' Disease [J].
Halstenberg, Jorg ;
Kranert, Wolfgang Tilman ;
Korkusuz, Hudayi ;
Mayer, Amelie ;
Ackermann, Hanns ;
Grunwald, Frank ;
Happel, Christian .
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2018, 57 (02) :43-49
[35]   Comparing pre-therapeutic 124I and 131I uptake tests with intra-therapeutic 131I uptake in benign thyroid disorders [J].
Guhne, Falk ;
Kuhnel, Christian ;
Freesmeyer, Martin .
ENDOCRINE, 2017, 56 (01) :43-53
[36]   Development and validation of nomograms for predicting survival in differentiated thyroid cancer patients with or without radioiodine therapy [J].
Ran, Bingyu ;
Gong, Jian ;
Shang, Jingjie ;
Wei, Feng ;
Xu, Hao .
FRONTIERS IN ONCOLOGY, 2023, 13
[37]   Guidelines on radioiodine therapy for differentiated thyroid carcinoma -: Impact on clinical practice [J].
Biermann, M ;
Pixberg, MK ;
Dörr, U ;
Dietlein, M ;
Schlemmer, H ;
Grimm, J ;
Zajic, T ;
Nestle, U ;
Ladner, S ;
Sepehr-Rezai, S ;
Rosenbaum, S ;
Puskás, C ;
Fostitsch, P ;
Heinecke, A ;
Schuck, A ;
Willich, N ;
Schmid, KW ;
Dralle, H ;
Schober, O .
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (06) :229-+
[38]   Treatment of advanced differentiated thyroid carcinoma with high activity radioiodine therapy [J].
Haq, MS ;
McCready, RV ;
Harmer, CL .
NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (08) :799-805
[39]   Dosimetric methodology for 131I therapy for benign thyroid diseases [J].
Piron, B. ;
Broggio, D. ;
Bardies, M. ;
Barrau, C. ;
Kotzki, P. O. ;
Boudousq, V .
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2020, 44 (04) :261-266
[40]   The Effect of Posttherapy 131I SPECT/CT on Risk Classification and Management of Patients with Differentiated Thyroid Cancer [J].
Grewal, Ravinder K. ;
Tuttle, R. Michael ;
Fox, Joseph ;
Borkar, Sunita ;
Chou, Joanne F. ;
Gonen, Mithat ;
Strauss, H. William ;
Larson, Steven M. ;
Schoeder, Heiko .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (09) :1361-1367